Antibody Aggregate Removal by Multimodal Chromatography
Molecules · 29.05.2025 · 30 (11) · 2363
DOI: 10.3390/molecules30112363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 29.05.2025. Verfasst von Veronika Rupčíková und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biochemical Engineering, Institute of Chemical and Environmental Engineering, Faculty of Chemical and Food Technology, Slo…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Protein Aggregates, Chromatography. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency, Scientific Grant Agency of the Ministry of Education, Science, Research, and Sports of the Slovak Republic and the Slovak Academy of Sciences.
Abstract (Originalsprache)
The growing demand for therapeutic monoclonal antibodies (mAbs) has heightened the need for efficient and scalable purification strategies. A major challenge in downstream processing is the removal of antibody aggregates, which can compromise drug safety, efficacy, and regulatory compliance. This review explores the use of multimodal chromatography for aggregate separation, providing an in-depth analysis of commercially available resins and emerging adsorbent prototypes. It also examines the mechanisms of aggregate formation during bioprocessing. A comparative evaluation of conventional single-mode chromatography techniques—affinity, ion exchange, and hydrophobic interaction—is presented alongside multimodal chromatography, which integrates ion-exchange, hydrophobic, and other non-covalent interactions for enhanced aggregate clearance and process flexibility. The review primarily assesses commercial multimodal resins in terms of aggregate removal efficiency, binding capacity, and scalability. Additionally, advancements in prototype resins and multimodal membranes are discussed. Finally, the advantages, limitations, and future directions of multimodal chromatography in mAb aggregate removal are outlined. As purification demands continue to evolve, multimodal chromatography is poised to play an increasingly critical role in achieving the high purity standards required for therapeutic antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biochemical Engineering, Institute of Chemical and Environmental Engineering, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, 812 37 Bratislava, Slovak…
ORCID-Profile: Milan Polakovič
Förderung
- Slovak Research and Development Agency
- Scientific Grant Agency of the Ministry of Education, Science, Research, and Sports of the Slovak Republic and the Slovak Academy of Sciences
Zitieren
APA
Rupčíková, V., Molnár, T., Kurák, T., & Polakovič, M. (2025). Antibody Aggregate Removal by Multimodal Chromatography. Molecules, 30(11), 2363. https://doi.org/10.3390/molecules30112363
Vancouver
Rupčíková V, Molnár T, Kurák T, Polakovič M. Antibody Aggregate Removal by Multimodal Chromatography. Molecules. 2025;30(11):2363. doi:10.3390/molecules30112363
BibTeX
@article{Rupkov2025,
author = {Rupčíková, Veronika and Molnár, Tomáš and Kurák, Tomáš and Polakovič, Milan},
title = {Antibody Aggregate Removal by Multimodal Chromatography},
journal = {Molecules},
year = {2025},
volume = {30},
number = {11},
pages = {2363},
doi = {10.3390/molecules30112363}
}
EUVIMED